You're contacting media contact of this press release:
The new program is based on the administration of a single injectable weight loss medication per week, and is popular under the brand names Wegovy, Ozempic, and Rybelus.More details can be found at https://www.bellevueweightloss.infoThe substance – semaglutide – has been approved by the FDA for weight loss and blood sugar management. The newly available medication mimics the GLP-1 hormone – an essential factor regulating appetite and the perception of hunger. An effective solution for weight loss, the program has been...
Otoño Silva, MD
Interventional Orthopedics of Washington
https://iowmed.com
+1-425-326-1665
1515 116th Ave NE Suite 202, Bellevue, WA 98004, United States
This press release is issued by Interventional Orthopedics of Washington